{
    "2021-10-12": [
        [
            {
                "time": "2021-10-25",
                "original_text": "Lilly Confirms Date and Conference Call for Third-Quarter 2021 Financial Results Announcement",
                "features": {
                    "keywords": [
                        "Lilly",
                        "conference call",
                        "third-quarter",
                        "financial results"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-09-06",
                "original_text": "Roche's (RHHBY) AD Drug Gets Breakthrough Therapy Status",
                "features": {
                    "keywords": [
                        "Roche",
                        "AD Drug",
                        "Breakthrough Therapy Status"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}